Invamed
  1. Companies
  2. Products
  3. TROKAMED - Cohen Probes

AtlasModel CoCr - Drug Eluting Coronary Stent System

SHARE

Atlas is a coronary balloon-expandable CoCr (L605) stent system consisting of everolimus particles. It is indicated for de novo and in-stent restenotic lesions in patients with coronary artery disease

Most popular related searches

Including acute coronary syndrome acute myocardial infarction or unstable angina and/or concomitant diabetes mellitus to improve luminal diameter and reduce restenosis within the stent and at the stent edges in native coronary arteries, de novo chronic total coronary occlusions, and improving coronary artery luminal diameter in patients.

Atlas?‘s delivery system minimizes the negative effects of the procedure, protecting the carina tip from being crushed or damaged they are applied in the following cases:

  • Unsatisfactory result of a PTCA procedure (residual stenosis)
  • Inner vessel membrane delamination
  • Vessel wall elasticity disorders and pressure from the outside

Atlas?stent system easily adapts its shape to the arterial wall and does not dislocate itself after deployment. The elasticity of the stent as well as the flexibility of the delivery system allows the use of Atlas?even in tortuous vessels.

The stent system is indicated reference vessel diameters of ≥ 2.25 mm to ≤ 4.25 mm and a lesion length of ≤ 27 mm

  • Made of CobaltCrome L605 laser cutting 
  • Increased conformability within unique open-cell design technology
  • Excellent radial force
  • The polymer layers release everolimus in a time–the controlled process of their slow degradation, inhibiting the formation process.
  • High flexibility of the Atlas? stent effects in excellent adaptation to vessel curvature
  • The special construction of the stent provides a good adhere to the arterial wall
  • Radiopaque markers on the stent endings allow precise implantation
  • The special construction of the delivery system makes to correction of stent position inside a vessel possible even after the partial stent release.
  • Optimized radial force to reduce thrombosis and neointima hyperplasia
  • Increased flexibility in severe bend situations
  • Precise deployment with a simplified single-operator system
  • Ideally fits the narrow and the tortuous lesions
  • Innovative coating for a consistent and controlled drug delivery
  • Superior flexibility and proven drug release

Balloon Diameter: 2.0 mm - 5.0 mm
Balloon Lenght: 10 mm, 15 mm, 17 mm, 20mm, 26 mm, 30mm
Catheter Shaft: RX
Catheter Lenght: 120 cm,150 cm
Radiopasity: Pt-Ir Marker
Applicable Guidewire: 0.014"
Drug/Quantity: Sirolimus 1µg/mm²